Skip to content
Get alerts
GovInfoNow
Use caution Drug recall · FDA · Published April 9, 2013

Aurobindo Recalls Lisinopril 30mg Due to Label Error

Aurobindo Pharma recalls 1776 bottles of Lisinopril 30mg tablets due to incorrect strength labeling. Check your lot numbers for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-498-2013DrugAurobindo Pharma ›
Take action

Contact the company

Recalling firmAurobindo Pharma USA Inc666 Plainsboro Rd. Suite 210 · Plainsboro, NJ 08536-3004
✎ GovInfoNow plain-language explainer

Aurobindo Pharma USA Inc is recalling one lot of Lisinopril Tablets, USP, 30 mg because the side display panel of the label shows an incorrect strength. The recall involves 1776 bottles distributed nationwide. No remedy or specific action steps are currently stated in the record. Read more at govinfonow.com/recall/48142-aurobindo-pharma-usa-inc-recalls-lisinopril-tablets-usp-30-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/48142-aurobindo-pharma-usa-inc-recalls-lisinopril-tablets-usp-30-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-498-2013

Cite this page

“Aurobindo Recalls Lisinopril 30mg Due to Label Error.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48142-aurobindo-pharma-usa-inc-recalls-lisinopril-tablets-usp-30-mg. Based on FDA recall #D-498-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-498-2013%22&limit=1).

The FDA announced on April 9, 2013, that Aurobindo Pharma USA Inc. is recalling Lisinopril Tablets, USP, 30 mg due to labeling errors showing an incorrect strength on the side display panel. The agency classified the recall as Class III.

How to tell if you have it

  • Brand: Aurobindo Pharma
  • Product: Lisinopril Tablets, USP, 30 mg
  • NDC: 65862-041-01
  • Lot codes: KP3012001-A, KP3012002-A
  • Expiration dates: 12/13
  • Quantity: 1776 bottles

The hazard

The hazard involves a labeling error where the declared strength on the side display panel of the label is incorrect. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Aurobindo Pharma USA Inc has 32 other recalls on record since October 17, 2014. Other recent recalls include an April 16, 2026 American Regent Levocarnitine Injection recall for a missing label hazard and an August 19, 2026 American Health Packaging Buprenorphine Tablets recall for a label mix-up hazard.

How to tell if you have this one

Look for Lisinopril Tablets, USP, 30 mg, Rx only, in bottles containing 100 tablets. The NDC is 65862-041-01. Check the lot numbers KP3012001-A and KP3012002-A, both with an expiration date of 12/13.

  • Brand
    Aurobindo Pharma
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Apr 9, 201312. FDA classified it Class III: May 30, 201323. Published in FDA’s Enforcement Report: Jun 5, 201334. FDA terminated the recall: Jan 23, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Other Aurobindo Pharma recalls

Aurobindo Pharma USA Inc recalls Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279
July 23, 2026Aurobindo Pharma USA Inc recalls Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles,
July 11, 2024

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc.,
Ajanta Pharma · September 17, 2026Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals · September 15, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-498-2013 (April 9, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-498-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA